BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BHI Elects MedImmune (AZN)'s Reg Seeto, M.D. to Board of Directors


12/19/2013 6:53:59 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

ROCKVILLE, Md. and BALTIMORE, Dec. 19, 2013 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today that Reg Seeto, M.D., has been appointed to the BHI Board of Directors. Dr. Seeto currently serves as Vice President, Head of Partnering & Strategy at MedImmune, the global biologics research and development arm of AstraZeneca.

"It is a pleasure to welcome Reg to the BHI Board of Directors," said Doug Liu, Chair, BHI Board of Directors, and Senior Vice President of Global Operations for Qiagen. "Reg's background in business development and partnering strategy will be an important asset to our Board as we give counsel to BHI in its fostering of startups in Central Maryland. We look forward to his contributions to this Board, to the BHI organization, and to the biohealth startup community."

Dr. Seeto rejoined the MedImmune Leadership Team in 2013 to lead the Partnering and Strategy Group after having spent a year as an executive abroad for AstraZeneca. He is responsible for MedImmune's Business Development and Strategy teams, which deliver external partnership strategy for the organization.

"It is an honor to be appointed to the BHI Board of Directors," said Dr. Seeto. "MedImmune has a strong interest in strengthening Maryland as a premiere bioscience cluster, and I look forward to working with BHI to advance its mission of developing Central Maryland into a center for commercialization and entrepreneurialism."

From 2011 to 2012, Dr. Seeto was on an expatriate assignment as the President of AstraZeneca Thailand, where he was the first MedImmune executive to participate in a talent exchange and development program with AstraZeneca. Under his leadership, the organization achieved its sales targets for the first time in five years and was awarded a company leadership award for management of the country's worst floods in more than half a century.

Dr. Seeto originally joined MedImmune in 2008 as the Vice President of Global Strategic Marketing and Portfolio Management where he worked closely with the R&D leadership team. He was later promoted to the MedImmune Executive Team (MET) and established the Corporate Development and Strategy Group. Dr. Seeto has previous experience with Schering Plough/Organon Biosciences and Boehringer Ingelheim Pharmaceuticals. His earlier work experience included serving as a consultant at McKinsey & Company and he started his career as a medical doctor involved in both clinical practice and research. He has also served as first author for papers published in peer-reviewed journals. Dr. Seeto holds his medical degree (with honors) from the University of Sydney, Australia

About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. Learn more at www.biohealthinnovation.org.

SOURCE BioHealth Innovation, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

MedImmune
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES